Hasil Pencarian - Jesper Jensen
- Menampilkan 1 - 15 hasil dari 15
-
1
Deep Trade Policy Options for Armenia: The Importance of Trade Facilitation, Services and Standards Liberalization oleh Jesper Jensen, David Tarr
Diterbitkan 2012-01-01
Artikel -
2
Deep Trade Policy Options for Armenia: The Importance of Trade Facilitation, Services and Standards Liberalization oleh Jesper Jensen, David Tarr
Diterbitkan 2011-08-01
Artikel -
3
-
4
-
5
Masked Spectrogram Prediction for Unsupervised Domain Adaptation in Speech Enhancement oleh Katerina Zmolikova, Michael Syskind Pedersen, Jesper Jensen
Diterbitkan 2024-01-01
Artikel -
6
Low Complexity DFT-Domain Noise PSD Tracking Using High-Resolution Periodograms oleh Ulrik Kjems, Jesper Jensen, Richard Heusdens, Richard C. Hendriks
Diterbitkan 2009-01-01
Artikel -
7
The Minimum Overlap-Gap Algorithm for Speech Enhancement oleh Poul Hoang, Zheng-Hua Tan, Jan Mark De Haan, Jesper Jensen
Diterbitkan 2022-01-01
Artikel -
8
Deep Spoken Keyword Spotting: An Overview oleh Ivan Lopez-Espejo, Zheng-Hua Tan, John H. L. Hansen, Jesper Jensen
Diterbitkan 2022-01-01
Artikel -
9
-
10
-
11
-
12
MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction oleh Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W. Hansen, Magnus T. Jensen, Henrik U. Andersen, Peter Rossing, Tina Vilsbøll, Peter G. Jørgensen
Diterbitkan 2020-10-01
Artikel -
13
Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejec... oleh Julie Hempel Larsen, Massar Omar, Jesper Jensen, Camilla Fuchs Andersen, Caroline Michaela Kistrup, Mikael Kjær Poulsen, Lars Videbæk, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller
Diterbitkan 2023-02-01
Artikel -
14
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker) oleh Massar Omar, Jesper Jensen, Caroline Kistorp, Kurt Højlund, Lars Videbæk, Christian Tuxen, Julie H. Larsen, Camilla F. Andersen, Finn Gustafsson, Lars Køber, Morten Schou, Jacob Eifer Møller
Diterbitkan 2022-02-01
Artikel -
15
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF) oleh Jesper Jensen, Massar Omar, Caroline Kistorp, Mikael Kjær Poulsen, Christian Tuxen, Ida Gustafsson, Lars Køber, Finn Gustafsson, Emil Fosbøl, Niels Eske Bruun, Lars Videbæk, Peter Hartmund Frederiksen, Jacob Eifer Møller, Morten Schou
Diterbitkan 2019-06-01
Artikel